The Food and Drug Administration will allow cosmetic drug and device maker Allergan Inc. to market its stomach-restricting Lap-Band to millions of new patients — patients who are less obese than those currently using the device. Eve Troeh has more.
The Senate Judiciary Committee holds hearings today on how best to combat online piracy. We talk to the chairman of that committee, Sen. Patrick Leahy (D-Vt.) about the aggressive approach he would like to see.
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
The governing body that controls web domain names is preparing for what it calls a land rush. Soon, you might be seeing not just .com and .net but .eco, .flowers, .god, .gay, and dot just about anything else you can think of.
Several multinational oil companies have been hacked in recent months, using methods that are actually very simple. What does that say about corporate computer security?
After a series of Toyota recalls, NASA — that's right, the National Aeronautics and Space Administration — is expected to publish its analysis of the so-called "runaway Toyotas" today. David Gura has more.
Honeycomb is Google's first software designed specifically for tablets. The company hopes to get Android software running on as many tablets as possible rather than building tablets itself.
Freakonomics Radio's Stephen Dubner talks to Kai Ryssdal about why he believes the future of food lies with those who are trying to bring the scientific method into the kitchen.
